LSL Pharma Group (LSL.V) Stock Price
LSL Pharma Group Price
Revenue has compounded at 42.9% per year over the past 5 years to 28.74 M CAD. LSL Pharma Group's net margin stands at -9.8%, up from -20.3% several years earlier.
LSL Pharma Group stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
LSL Pharma Group business model & stock analysis
Frequently asked questions about LSL Pharma Group
Converted at the current exchange rate, the LSL Pharma Group share trades at 0.19 EUR (0.30 CAD).
The revenue cannot currently be calculated for LSL Pharma Group.
The profit cannot currently be calculated for LSL Pharma Group.
The P/E ratio cannot be calculated for LSL Pharma Group at the moment.
The P/S cannot be calculated for LSL Pharma Group currently.
The Eulerpool Quality Score for LSL Pharma Group is 4/10.
The ISIN of LSL Pharma Group is CA50190N1042. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of LSL Pharma Group is LSL.V. The ticker symbol is used to trade LSL Pharma Group shares on the stock exchange.
LSL Pharma Group stock
LSL Pharma Group Peer Group
LSL Pharma Group FIGI
All fundamentals and in-depth analysis of LSL Pharma Group
Our stock analysis for LSL Pharma Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LSL Pharma Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.